Modulation of Inducible Nitric Oxide Synthase Expression by the Attaching and Effacing Bacterial Pathogen Citrobacter rodentium in Infected Mice
暂无分享,去创建一个
B. Finlay | K. Jacobson | B. Vallance | W. Deng | Crystal Chan | M. de Grado | B. Vallance | C. Chan | B. Finlay
[1] M. Hensel,et al. Salmonella Pathogenicity Island 2 Mediates Protection of Intracellular Salmonella from Reactive Nitrogen Intermediates , 2002, The Journal of experimental medicine.
[2] B. Finlay,et al. Mice Lacking T and B Lymphocytes Develop Transient Colitis and Crypt Hyperplasia yet Suffer Impaired Bacterial Clearance during Citrobacter rodentium Infection , 2002, Infection and Immunity.
[3] R. Forsythe,et al. Lipopolysaccharide-Induced Enterocyte-Derived Nitric Oxide Induces Intestinal Monolayer Permeability in an Autocrine Fashion , 2002, Shock.
[4] J. Gordon,et al. Molecular Regulation of Urothelial Renewal and Host Defenses during Infection with Uropathogenic Escherichia coli * 210 , 2002, The Journal of Biological Chemistry.
[5] S. Clare,et al. Impaired Resistance and Enhanced Pathology During Infection with a Noninvasive, Attaching-Effacing Enteric Bacterial Pathogen, Citrobacter rodentium, in Mice Lacking IL-12 or IFN-γ , 2002, The Journal of Immunology.
[6] F. Fang,et al. The Global Regulator ArcA Controls Resistance to Reactive Nitrogen and Oxygen Intermediates in Salmonella enterica Serovar Enteritidis , 2002, Infection and Immunity.
[7] J. Rask-Madsen,et al. Colonic Production of Nitric Oxide Gas in Ulcerative Colitis, Collagenous Colitis and Uninflamed Bowel , 2002, Scandinavian journal of gastroenterology.
[8] A. Gobert,et al. Helicobacter pylori arginase inhibits nitric oxide production by eukaryotic cells: A strategy for bacterial survival , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[9] T. Eisenstein. Implications of Salmonella-induced nitric oxide (NO) for host defense and vaccines: NO, an antimicrobial, antitumor, immunosuppressive and immunoregulatory molecule. , 2001, Microbes and infection.
[10] F. Fang,et al. Salmonella evasion of the NADPH phagocyte oxidase. , 2001, Microbes and infection.
[11] P. Hellström,et al. Rectal nitric oxide assessment in children with Crohn disease and ulcerative colitis. Indicator of ileocaecal and colorectal affection. , 2001, Scandinavian journal of gastroenterology.
[12] B. Finlay,et al. Enteropathogenic Escherichia coli Infection Induces Expression of the Early Growth Response Factor by Activating Mitogen-Activated Protein Kinase Cascades in Epithelial Cells , 2001, Infection and Immunity.
[13] S. Savkovic,et al. EPEC-activated ERK1/2 participate in inflammatory response but not tight junction barrier disruption. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[14] B. Finlay,et al. Locus of Enterocyte Effacement from Citrobacter rodentium: Sequence Analysis and Evidence for Horizontal Transfer among Attaching and Effacing Pathogens , 2001, Infection and Immunity.
[15] D. Holden,et al. Macrophage Nitric Oxide Synthase Associates with Cortical Actin but Is Not Recruited to Phagosomes , 2001, Infection and Immunity.
[16] N. Sato,et al. Cyclooxygenase-2 downregulates inducible nitric oxide synthase in rat intestinal epithelial cells. , 2001, American journal of physiology. Gastrointestinal and liver physiology.
[17] D. Philpott,et al. Innate immune responses of epithelial cells following infection with bacterial pathogens. , 2001, Current opinion in immunology.
[18] N. Brot,et al. Peptide methionine sulfoxide reductase from Escherichia coli and Mycobacterium tuberculosis protects bacteria against oxidative damage from reactive nitrogen intermediates , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[19] Gail Hecht. Microbes and microbial toxins: paradigms for microbial-mucosal interactions. VII. Enteropathogenic Escherichia coli: physiological alterations from an extracellular position. , 2001, American Journal of Physiology - Gastrointestinal and Liver Physiology.
[20] S. Clare,et al. Understanding mucosal responsiveness: lessons from enteric bacterial pathogens. , 2001, Seminars in immunology.
[21] N. Tangthawornchaikul,et al. Burkholderia pseudomallei Interferes with Inducible Nitric Oxide Synthase (iNOS) Production: A Possible Mechanism of Evading Macrophage Killing , 2001, Microbiology and immunology.
[22] E. Boedeker,et al. Complete Nucleotide Sequence and Analysis of the Locus of Enterocyte Effacement from Rabbit Diarrheagenic Escherichia coli RDEC-1 , 2001, Infection and Immunity.
[23] B. Finlay,et al. Enteropathogenic Escherichia coli mediates antiphagocytosis through the inhibition of PI 3‐kinase‐dependent pathways , 2001, The EMBO journal.
[24] S. Dahan,et al. Implication of Mitogen-Activated Protein Kinases in T84 Cell Responses to Enteropathogenic Escherichia coli Infection , 2001, Infection and Immunity.
[25] B. Christensson,et al. Downregulation of bactericidal peptides in enteric infections: A novel immune escape mechanism with bacterial DNA as a potential regulator , 2001, Nature Medicine.
[26] A. Steigerwalt,et al. Citrobacter rodentium, the Causative Agent of Transmissible Murine Colonic Hyperplasia, Exhibits Clonality: Synonymy of C. rodentium and Mouse-PathogenicEscherichia coli , 2000, Journal of Clinical Microbiology.
[27] B. Finlay,et al. Human Response to Escherichia coliO157:H7 Infection: Antibodies to Secreted Virulence Factors , 2000, Infection and Immunity.
[28] C. Nathan,et al. Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[29] B. Finlay,et al. Exploitation of host cells by enteropathogenic Escherichia coli. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[30] Moilanen,et al. Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor‐κB‐dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin , 2000 .
[31] P. Kubes. Inducible nitric oxide synthase: a little bit of good in all of us , 2000, Gut.
[32] B. Finlay,et al. Role of EspB in Experimental Human EnteropathogenicEscherichia coli Infection , 2000, Infection and Immunity.
[33] M. Kagnoff,et al. Analysis by High Density cDNA Arrays of Altered Gene Expression in Human Intestinal Epithelial Cells in Response to Infection with the Invasive Enteric BacteriaSalmonella * , 2000, The Journal of Biological Chemistry.
[34] B. P. McNamara,et al. A Large Toxin from Pathogenic Escherichia coli Strains That Inhibits Lymphocyte Activation , 2000, Infection and Immunity.
[35] B. Finlay,et al. Enteropathogenic Escherichia coli (EPEC) attachment to epithelial cells: exploiting the host cell cytoskeleton from the outside , 2000, Cellular microbiology.
[36] B. Zabel,et al. Citrobacter rodentium espB Is Necessary for Signal Transduction and for Infection of Laboratory Mice , 1999, Infection and Immunity.
[37] I. Connerton,et al. Role of bacterial intimin in colonic hyperplasia and inflammation. , 1999, Science.
[38] W. Goldman,et al. Signalling and cellular specificity of airway nitric oxide production in pertussis , 1999, Cellular microbiology.
[39] S. Meltzer,et al. Increased expression and cellular localization of inducible nitric oxide synthase and cyclooxygenase 2 in Helicobacter pylori gastritis. , 1999, Gastroenterology.
[40] G. Dougan,et al. Citrobacter rodentium Infection in Mice Elicits a Mucosal Th1 Cytokine Response and Lesions Similar to Those in Murine Inflammatory Bowel Disease , 1999, Infection and Immunity.
[41] J. Wallace,et al. Prolonged colonic epithelial hyporesponsiveness after colitis: role of inducible nitric oxide synthase. , 1999, American journal of physiology. Gastrointestinal and liver physiology.
[42] W. MacNaughton,et al. Role of nitric oxide in inflammation-induced suppression of secretion in a mouse model of acute colitis. , 1998, The American journal of physiology.
[43] G. Dougan,et al. Enteropathogenic and enterohaemorrhagic Escherichia coli : more subversive elements , 1998, Molecular microbiology.
[44] R. Hegele,et al. Two Enteropathogenic Escherichia coli Type III Secreted Proteins, EspA and EspB, Are Virulence Factors , 1998, The Journal of experimental medicine.
[45] Jung Mogg Kim,et al. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. , 1998, American journal of physiology. Gastrointestinal and liver physiology.
[46] J. Westwick,et al. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines , 1998, Gut.
[47] A. Rudensky,et al. Medullary Thymic Epithelium: A Mosaic of Epithelial “Self”? , 1998, The Journal of experimental medicine.
[48] B. Finlay,et al. Enteropathogenic E. coli (EPEC) Transfers Its Receptor for Intimate Adherence into Mammalian Cells , 1997, Cell.
[49] S. Savkovic,et al. Activation of NF-κB in intestinal epithelial cells by enteropathogenic Escherichia coli. , 1997, American journal of physiology. Cell physiology.
[50] S. Savkovic,et al. Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils , 1996, Infection and immunity.
[51] J. Abraham,et al. Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytes. , 1996, The American journal of physiology.
[52] J. Beesley,et al. Expression of nitric oxide synthase in ulcerative colitis , 1996, European journal of clinical investigation.
[53] I. Charles,et al. Altered immune responses in mice lacking inducible nitric oxide synthase , 1995, Nature.
[54] F. Patricio,et al. [Morphometrics of the small intestine in children with diarrhea due to classical enteropathogenic Escherichia coli and to environmental asymptomatic enteropathy]. , 1995, Revista da Associacao Medica Brasileira.
[55] R. Robins-Browne,et al. Adherence characteristics of attaching and effacing strains of Escherichia coli from rabbits , 1994, Infection and immunity.
[56] S. Falkow,et al. The eae gene of Citrobacter freundii biotype 4280 is necessary for colonization in transmissible murine colonic hyperplasia , 1993, Infection and immunity.
[57] J. Walker-Smith,et al. Enteropathogenic Escherichia coli and life threatening chronic diarrhoea. , 1991, Gut.
[58] L. Trabulsi,et al. Protracted Diarrhea: The Importance of the Enteropathogenic E. coli (EPEC) Strains and Salmonella in Its Genesis , 1989, Journal of pediatric gastroenterology and nutrition.
[59] G. L. Coleman,et al. Transmissible Murine Colonic Hyperplasia , 1978, Veterinary pathology.
[60] D. Kopecko,et al. Breaching the mucosal barrier by stealth: an emerging pathogenic mechanism for enteroadherent bacterial pathogens. , 2001, The Journal of clinical investigation.
[61] A. Fruth,et al. Enterohemorrhagic Escherichia coli. , 2001, Contributions to microbiology.
[62] B. Finlay,et al. Gut feelings: enteropathogenic E. coli (EPEC) interactions with the host. , 2000, Annual review of cell and developmental biology.
[63] E. Moilanen,et al. Regulation of nitric oxide production in cultured human T84 intestinal epithelial cells by nuclear factor-kappa B-dependent induction of inducible nitric oxide synthase after exposure to bacterial endotoxin. , 2000, Alimentary pharmacology & therapeutics.
[64] B. Finlay,et al. Enteropathogenic Escherichia coli inhibits phagocytosis. , 1999, Infection and immunity.
[65] B. China,et al. The locus for enterocyte effacement (LEE) of enteropathogenic Escherichia coli (EPEC) from dogs and cats. , 1999, Advances in experimental medicine and biology.
[66] C. Szabó,et al. Bacterial induction of inducible nitric oxide synthase in cultured human intestinal epithelial cells. , 1998, Gastroenterology.
[67] D. Schauer. Murine Colonic Hyperplasia , 1994 .
[68] D. Portnoy,et al. Molecular Genetics of Bacterial Pathogenesis , 1994 .